{"id":11094,"date":"2022-10-24T12:03:35","date_gmt":"2022-10-24T10:03:35","guid":{"rendered":"https:\/\/ggba.swiss\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/"},"modified":"2023-07-04T13:44:06","modified_gmt":"2023-07-04T11:44:06","slug":"cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/","title":{"rendered":"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard"},"content":{"rendered":"\n<p><a href=\"https:\/\/cordis.com\/emea\/home?regionPref=63966\" target=\"_blank\" rel=\"noopener\">Cordis<\/a>, d\u00e9veloppeur et fabricant mondial de technologies cardiovasculaires interventionnelles, a conclu un accord pour acqu\u00e9rir <a href=\"https:\/\/medalliance.com\/\" target=\"_blank\" rel=\"noopener\">MedAlliance<\/a> afin de renforcer sa position dans les technologies de ballons \u00e0 \u00e9lution de m\u00e9dicaments. Cordis dispose d\u2019une longue exp\u00e9rience dans les produits cardiovasculaires de haute qualit\u00e9 et peu invasifs, ayant \u00e9tabli une forte pr\u00e9sence mondiale avec des op\u00e9rations dans plus de 70 pays.<\/p>\n<p>MedAlliance recevra des paiements \u00e9chelonn\u00e9s en fonction de l&rsquo;atteinte des objectifs r\u00e9glementaires \u00e0 hauteur de USD 125 millions, et des versements commerciaux \u00e9chelonn\u00e9s \u00e0 hauteur de USD 775 millions jusqu&rsquo;en 2029, ce qui porte la transaction totale \u00e0 USD 1,135 milliard.<\/p>\n<p>Fond\u00e9e en 2008 et bas\u00e9e \u00e0 Nyon (canton de Vaud), MedAlliance se concentre sur les produits combin\u00e9s m\u00e9dicament-dispositif, initialement pour le traitement des maladies coronariennes et des art\u00e8res p\u00e9riph\u00e9riques. Son produit phare, SELUTION SLR (Sustained Limus Release), est une nouvelle plateforme technologique de ballon \u00e0 \u00e9lution de m\u00e9dicaments qui utilise des micro-r\u00e9servoirs sph\u00e9riques fabriqu\u00e9s \u00e0 partir de polym\u00e8res biod\u00e9gradables m\u00e9lang\u00e9s \u00e0 du sirolimus, un m\u00e9dicament anti-rest\u00e9notique qui a fait ses preuves.<\/p>\n<p>Ces micro-r\u00e9servoirs permettent une lib\u00e9ration contr\u00f4l\u00e9e et prolong\u00e9e du m\u00e9dicament jusqu&rsquo;\u00e0 90 jours, faisant de SELUTION le seul ballon \u00e0 \u00e9lution de m\u00e9dicament utilisant des micro-r\u00e9servoirs et offrant le profil de lib\u00e9ration pharmacocin\u00e9tique le plus efficace de tous les dispositifs sur le march\u00e9.<\/p>\n<h4>Un dispositif r\u00e9volutionnaire mis au point dans la Health Valley<\/h4>\n<p>Au c\u0153ur de la \u00ab\u00a0<a href=\"https:\/\/www.republic-of-innovation.org\/HealthValley\/\" target=\"_blank\" rel=\"noopener\">Health Valley<\/a>\u00a0\u00bb, MedAlliance est la premi\u00e8re entreprise de ballons \u00e0 \u00e9lution m\u00e9dicamenteuse au monde \u00e0 avoir re\u00e7u le <a href=\"https:\/\/ggba.swiss\/fr\/societe-medtech-medalliance-leve-plus-de-usd-50-millions-commercialiser-ballons-a-elution-de-medicament\/\" target=\"_blank\" rel=\"noopener\">statut de \u00ab\u00a0Breakthrough Device Designation\u00a0\u00bb de la FDA am\u00e9ricaine<\/a> pour un DEB au sirolimus, qui a r\u00e9cemment re\u00e7u le statut de \u00ab\u00a0breakthrough\u00a0\u00bb pour SELUTION SLR dans le traitement des l\u00e9sions ath\u00e9roscl\u00e9rotiques dans les art\u00e8res coronaires natives.<\/p>\n<p>\u00c0 ce jour, environ 9\u2019200 dispositifs Selution ont \u00e9t\u00e9 utilis\u00e9s dans le commerce, tandis que plus de 2\u2019000 patients ont \u00e9t\u00e9 trait\u00e9s avec dans le cadre d&rsquo;essais cliniques.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dans le cadre d&rsquo;une transaction totale pouvant atteindre USD 1,135 milliard, MedAlliance a sign\u00e9 un accord de sortie avec Cordis, un leader mondial des technologies cardiovasculaires et endovasculaires interventionnelles.<\/p>\n","protected":false},"author":3,"featured_media":11095,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1054,1060,1069],"class_list":["post-11094","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-investment-fr","tag-medtech-fr","tag-pharma-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Dans le cadre d&#039;une transaction totale pouvant atteindre USD 1,135 milliard, MedAlliance a sign\u00e9 un accord de sortie avec Cordis, un leader mondial des technologies cardiovasculaires et endovasculaires interventionnelles.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-24T10:03:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:44:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard\",\"datePublished\":\"2022-10-24T10:03:35+00:00\",\"dateModified\":\"2023-07-04T11:44:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/\"},\"wordCount\":354,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg\",\"keywords\":[\"Investment\",\"Medtech\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/\",\"name\":\"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg\",\"datePublished\":\"2022-10-24T10:03:35+00:00\",\"dateModified\":\"2023-07-04T11:44:06+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/","og_locale":"fr_FR","og_type":"article","og_title":"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard - Greater Geneva Bern area","og_description":"Dans le cadre d'une transaction totale pouvant atteindre USD 1,135 milliard, MedAlliance a sign\u00e9 un accord de sortie avec Cordis, un leader mondial des technologies cardiovasculaires et endovasculaires interventionnelles.","og_url":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2022-10-24T10:03:35+00:00","article_modified_time":"2023-07-04T11:44:06+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard","datePublished":"2022-10-24T10:03:35+00:00","dateModified":"2023-07-04T11:44:06+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/"},"wordCount":354,"image":{"@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg","keywords":["Investment","Medtech","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/","url":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/","name":"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg","datePublished":"2022-10-24T10:03:35+00:00","dateModified":"2023-07-04T11:44:06+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Cordis-MedAlliance-SLR-Selution-630x380-1-2.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/cordis-va-acquerir-la-medtech-vaudoise-medalliance-pour-usd-11-milliard\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Cordis va acqu\u00e9rir la medtech vaudoise MedAlliance pour USD 1,1 milliard"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=11094"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11094\/revisions"}],"predecessor-version":[{"id":18257,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/11094\/revisions\/18257"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/11095"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=11094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=11094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=11094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}